Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):E5116. doi: 10.1073/pnas.1513935112. Epub 2015 Aug 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Neutralizing / therapeutic use*
  • Coronavirus Infections / therapy*
  • Humans
  • Middle East Respiratory Syndrome Coronavirus / pathogenicity*
  • Spike Glycoprotein, Coronavirus / immunology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus